Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Yoga Training on Menopausal Symptoms on Menopausal Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04695808
Recruitment Status : Recruiting
First Posted : January 5, 2021
Last Update Posted : January 5, 2021
Sponsor:
Information provided by (Responsible Party):
Arzu Abiç, Eastern Mediterranean University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Parallel to the increase in life expectancy by years, the population of women living in the post-menopausal period is also increasing. In order to have a healthy menopause, which is an important part of women's life, it is thought that the adoption of yoga practice without health risks by women and its implementation as a lifestyle may be effective in reducing the symptoms of menopause experienced by women. In line with this information, it is aimed to determine the effect of yoga training on menopausal symptoms. The research will be carried out with menopausal women between the ages of 40-60 in Famagusta region. Women will be divided into two groups as intervention and control. Personal information form and menopause rating scale will be used in the research. The intervention group will be given yoga practice two days a week for 10 weeks. Menopause rating scale will be applied to the intervention and control group before and after the research.

Condition or disease Intervention/treatment Phase
Menopause Behavioral: yoga Not Applicable

Detailed Description:
Parallel to the increase in life expectancy by years, the population of women living in the post-menopausal period is also increasing. In order to have a healthy menopause, which is an important part of women's life, it is thought that the adoption of yoga practice without health risks by women and its implementation as a lifestyle may be effective in reducing the symptoms of menopause experienced by women. In line with this information, it is aimed to determine the effect of yoga training on menopausal symptoms. The research will be carried out with menopausal women between the ages of 40-60 in Famagusta region. Women will be divided into two groups as intervention and control. Personal information form and menopause rating scale will be used in the research. The intervention group will be given yoga practice two days a week for 10 weeks. Menopause rating scale will be applied to the intervention and control group before and after the research.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: Single (Investigator)
Primary Purpose: Supportive Care
Official Title: The Effect of Yoga Training on Menopausal Symptoms on Menopausal Women
Actual Study Start Date : September 15, 2020
Actual Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 29, 2021
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: intervention group
Yoga practice will be done two days a week for 10 weeks.
 Behavioral: yoga
Yoga practice will be done two days a week for 10 weeks.
No Intervention: control group
no intervention


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. menopause rating scale [ Time Frame: 3 months ]
    It was developed in German by Schneider et al. In 1992 to measure the severity of menopausal symptoms and was adapted to English in 1996. MRT was adapted to Turkish by Gürkan in our country in 2005. There are "0 = None", "1 = Mild", "2 = Moderate", "3 = Severe" and "4 = Very severe" options for each item in the Likert-type scale consisting of 11 items including menopausal complaints. The total score of the scale is calculated based on the scores given for each item. The lowest score that can be obtained from the scale is 0, the highest score is 44.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Women aged 40-60 who are in menopause
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Willing to participate in research,
  • Can read and write in Turkish,
  • Open to communication,
  • Those who are between the ages of 40-60 and do not experience menstruation for at least one year, Do not use medication to treat menopausal symptoms,
  • No diagnosed musculoskeletal disease, no severe heart disease,
  • Not doing regular exercise and yoga,
  • Not surgically menopausal,
  • Women without psychiatric problems

Exclusion Criteria:

  • Refusing to participate in research,
  • Can't read and write Turkish,
  • Communication is not possible,
  • Those who are younger than 40 or older than 60 have experienced menstruation for at least one year
  • Using medication for the treatment of menopausal symptoms,
  • Those with a diagnosed musculoskeletal disease, severe heart disease,
  • Doing regular exercise and yoga,
  • Surgically menopausal, Women with psychiatric problems
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04695808


Contacts
Layout table for location contacts
Contact: Arzu Abiç 05488506060 ext 6301313 arzu.abic@gmail.com

Locations
Layout table for location information
Cyprus
Eastern Mediterranean University Recruiting
Famagusta, Cyprus, 90
Contact: Arzu Abic, PhD Student    05488506060    arzu.abic@gmail.com   
Sponsors and Collaborators
Eastern Mediterranean University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Arzu Abiç, Senior İnstructor, Eastern Mediterranean University
ClinicalTrials.gov Identifier: NCT04695808    
Other Study ID Numbers: g9987n5g
Duygu Yılmaz Vefikulucay ( Other Identifier: Eastern Mediterranean University )
First Posted: January 5, 2021    Key Record Dates
Last Update Posted: January 5, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Arzu Abiç, Eastern Mediterranean University:
menopause
yoga
symptoms